JP2025504363A5 - - Google Patents
Info
- Publication number
- JP2025504363A5 JP2025504363A5 JP2024540715A JP2024540715A JP2025504363A5 JP 2025504363 A5 JP2025504363 A5 JP 2025504363A5 JP 2024540715 A JP2024540715 A JP 2024540715A JP 2024540715 A JP2024540715 A JP 2024540715A JP 2025504363 A5 JP2025504363 A5 JP 2025504363A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263296774P | 2022-01-05 | 2022-01-05 | |
| US63/296,774 | 2022-01-05 | ||
| US202263417926P | 2022-10-20 | 2022-10-20 | |
| US63/417,926 | 2022-10-20 | ||
| PCT/US2023/060074 WO2023133394A1 (en) | 2022-01-05 | 2023-01-04 | Gamma delta t-cell-binding polypeptides and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025504363A JP2025504363A (ja) | 2025-02-12 |
| JPWO2023133394A5 JPWO2023133394A5 (https=) | 2025-12-26 |
| JP2025504363A5 true JP2025504363A5 (https=) | 2025-12-26 |
Family
ID=85199216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024540715A Pending JP2025504363A (ja) | 2022-01-05 | 2023-01-04 | γδＴ細胞結合ポリペプチド及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250066477A1 (https=) |
| EP (1) | EP4460521A1 (https=) |
| JP (1) | JP2025504363A (https=) |
| KR (1) | KR20240130130A (https=) |
| CN (1) | CN119213028A (https=) |
| AU (1) | AU2023205911A1 (https=) |
| CA (1) | CA3242658A1 (https=) |
| IL (1) | IL314073A (https=) |
| MX (1) | MX2024008389A (https=) |
| TW (1) | TW202334233A (https=) |
| WO (1) | WO2023133394A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025144974A1 (en) * | 2023-12-29 | 2025-07-03 | Absci Corporation | Half-life extending fc domain variants and uses thereof |
| WO2025140683A1 (zh) * | 2023-12-29 | 2025-07-03 | 北京鼎成肽源生物技术有限公司 | 表达趋化因子10和白介素15的工程化免疫细胞 |
| WO2026006719A1 (en) * | 2024-06-28 | 2026-01-02 | IN8bio, Inc. | Multifunctional molecules and methods of treatment |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| ES2375931T3 (es) | 1997-12-05 | 2012-03-07 | The Scripps Research Institute | Humanización de anticuerpo murino. |
| US7217797B2 (en) | 2002-10-15 | 2007-05-15 | Pdl Biopharma, Inc. | Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| PT1678314E (pt) | 2003-10-22 | 2012-11-27 | Keck Graduate Inst | Métodos de síntese de polipéptidos heteromultiméricos em levedura utilizando uma estratégia de conjugação haplóide |
| CN1961003B (zh) | 2004-03-31 | 2013-03-27 | 健泰科生物技术公司 | 人源化抗TGF-β抗体 |
| EP3129404B1 (en) * | 2014-04-10 | 2026-01-28 | LAVA Therapeutics N.V. | Immunoglobulins binding human vgamma9vdelta2 t cell receptors |
| GB201707048D0 (en) * | 2017-05-03 | 2017-06-14 | King S College London | Expansion of gamma delta cells, compositions, and methods of use thereof |
| EP3864045A2 (en) * | 2018-10-11 | 2021-08-18 | Inhibrx, Inc. | Dll3 single domain antibodies and therapeutic compositions thereof |
| CN113993893A (zh) * | 2019-02-01 | 2022-01-28 | 拉法医疗有限公司 | 新cd40结合抗体 |
| KR20220004751A (ko) * | 2019-05-04 | 2022-01-11 | 인히브릭스, 인크. | CLEC12a 결합 폴리펩타이드 및 이의 용도 |
| JP2023504185A (ja) * | 2019-12-03 | 2023-02-01 | アディセット バイオ， インコーポレイテッド | γδＴ細胞集団を多価薬剤で増殖させるための方法及びその組成物 |
| WO2021176373A1 (en) * | 2020-03-03 | 2021-09-10 | Janssen Biotech, Inc. | ꝩδ T CELLS AND USES THEREOF |
-
2023
- 2023-01-04 KR KR1020247026008A patent/KR20240130130A/ko active Pending
- 2023-01-04 IL IL314073A patent/IL314073A/en unknown
- 2023-01-04 CN CN202380016082.6A patent/CN119213028A/zh active Pending
- 2023-01-04 CA CA3242658A patent/CA3242658A1/en active Pending
- 2023-01-04 TW TW112100154A patent/TW202334233A/zh unknown
- 2023-01-04 US US18/726,347 patent/US20250066477A1/en active Pending
- 2023-01-04 WO PCT/US2023/060074 patent/WO2023133394A1/en not_active Ceased
- 2023-01-04 JP JP2024540715A patent/JP2025504363A/ja active Pending
- 2023-01-04 AU AU2023205911A patent/AU2023205911A1/en active Pending
- 2023-01-04 EP EP23704000.1A patent/EP4460521A1/en active Pending
-
2024
- 2024-07-02 MX MX2024008389A patent/MX2024008389A/es unknown